nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromodiphenhydramine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.0368	0.0642	CbGpPWpGaD
Bromodiphenhydramine—Captodiame—DRD3—bipolar disorder	0.0328	0.0767	CrCbGaD
Bromodiphenhydramine—Orphenadrine—GRIN1—bipolar disorder	0.0304	0.0711	CrCbGaD
Bromodiphenhydramine—Amitriptyline—NTRK2—bipolar disorder	0.0303	0.071	CrCbGaD
Bromodiphenhydramine—Captodiame—HTR2C—bipolar disorder	0.0275	0.0644	CrCbGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD5—bipolar disorder	0.0247	0.0432	CbGpPWpGaD
Bromodiphenhydramine—Diphenylpyraline—SLC6A3—bipolar disorder	0.0236	0.0553	CrCbGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD5—bipolar disorder	0.0208	0.0363	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—NTRK1—bipolar disorder	0.0187	0.0439	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.0185	0.0322	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.0167	0.0292	CbGpPWpGaD
Bromodiphenhydramine—Fluoxetine—HTR2C—bipolar disorder	0.0162	0.038	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.0148	0.0258	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.0145	0.0252	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—HTR1A—bipolar disorder	0.0144	0.0252	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD1—bipolar disorder	0.0139	0.0243	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—HTR2C—bipolar disorder	0.0139	0.0243	CbGpPWpGaD
Bromodiphenhydramine—Chlorphenamine—SLC6A3—bipolar disorder	0.0137	0.0322	CrCbGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD3—bipolar disorder	0.0135	0.0236	CbGpPWpGaD
Bromodiphenhydramine—Fluoxetine—SLC6A4—bipolar disorder	0.0134	0.0315	CrCbGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD4—bipolar disorder	0.0131	0.0229	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD2—bipolar disorder	0.0122	0.0213	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0121	0.0212	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.012	0.0209	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0117	0.0205	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0117	0.0205	CbGpPWpGaD
Bromodiphenhydramine—Benzphetamine—SLC6A3—bipolar disorder	0.0116	0.0272	CrCbGaD
Bromodiphenhydramine—Atomoxetine—SLC6A3—bipolar disorder	0.0115	0.027	CrCbGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0113	0.0198	CbGpPWpGaD
Bromodiphenhydramine—Cyclobenzaprine—HTR2A—bipolar disorder	0.0113	0.0264	CrCbGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD4—bipolar disorder	0.011	0.0192	CbGpPWpGaD
Bromodiphenhydramine—Atomoxetine—HTR2C—bipolar disorder	0.0104	0.0244	CrCbGaD
Bromodiphenhydramine—Fluoxetine—HTR2A—bipolar disorder	0.0103	0.0242	CrCbGaD
Bromodiphenhydramine—Chlorphenamine—SLC6A4—bipolar disorder	0.0103	0.0241	CrCbGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0103	0.0179	CbGpPWpGaD
Bromodiphenhydramine—Promazine—DRD4—bipolar disorder	0.01	0.0235	CrCbGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—GATA3—bipolar disorder	0.0094	0.0164	CbGpPWpGaD
Bromodiphenhydramine—Atomoxetine—SLC6A4—bipolar disorder	0.00864	0.0202	CrCbGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—HTR2A—bipolar disorder	0.00855	0.0149	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00849	0.0148	CbGpPWpGaD
Bromodiphenhydramine—Promazine—DRD1—bipolar disorder	0.00849	0.0199	CrCbGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.00839	0.0146	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—HTR2C—bipolar disorder	0.00817	0.0191	CrCbGaD
Bromodiphenhydramine—Doxepin—HTR1A—bipolar disorder	0.00793	0.0186	CrCbGaD
Bromodiphenhydramine—Amitriptyline—DRD3—bipolar disorder	0.00752	0.0176	CrCbGaD
Bromodiphenhydramine—Promazine—HTR2C—bipolar disorder	0.00726	0.017	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.00726	0.0127	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00719	0.0125	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—SLC6A3—bipolar disorder	0.00704	0.0165	CrCbGaD
Bromodiphenhydramine—Doxepin—SLC6A4—bipolar disorder	0.00677	0.0158	CrCbGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—DGKH—bipolar disorder	0.00675	0.0118	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—DRD2—bipolar disorder	0.00673	0.0158	CrCbGaD
Bromodiphenhydramine—Atomoxetine—HTR2A—bipolar disorder	0.00664	0.0155	CrCbGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.00657	0.0115	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00643	0.0112	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—HTR2C—bipolar disorder	0.00636	0.0149	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR2C—bipolar disorder	0.00632	0.0148	CrCbGaD
Bromodiphenhydramine—Imipramine—HTR1A—bipolar disorder	0.00617	0.0144	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR1A—bipolar disorder	0.00613	0.0144	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00604	0.0105	CbGpPWpGaD
Bromodiphenhydramine—Promazine—DRD2—bipolar disorder	0.00598	0.014	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00581	0.0101	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—SLC6A4—bipolar disorder	0.00527	0.0123	CrCbGaD
Bromodiphenhydramine—Imipramine—DRD2—bipolar disorder	0.00524	0.0123	CrCbGaD
Bromodiphenhydramine—Amitriptyline—SLC6A4—bipolar disorder	0.00523	0.0123	CrCbGaD
Bromodiphenhydramine—Amitriptyline—DRD2—bipolar disorder	0.00521	0.0122	CrCbGaD
Bromodiphenhydramine—Doxepin—HTR2A—bipolar disorder	0.0052	0.0122	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00477	0.00834	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00468	0.00817	CbGpPWpGaD
Bromodiphenhydramine—Promazine—HTR2A—bipolar disorder	0.00462	0.0108	CrCbGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—TACR1—bipolar disorder	0.00435	0.0076	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.00426	0.00744	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.00423	0.00739	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.00419	0.00731	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00409	0.00714	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—HTR2A—bipolar disorder	0.00405	0.00947	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR2A—bipolar disorder	0.00402	0.00942	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.00389	0.0068	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—TAC1—bipolar disorder	0.00355	0.00619	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00348	0.00607	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00334	0.00583	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.0033	0.00576	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00317	0.00554	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD5—bipolar disorder	0.00312	0.00544	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00311	0.00543	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00288	0.00503	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00288	0.00503	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00278	0.00486	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00269	0.0047	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00269	0.0047	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.0026	0.00455	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00253	0.00442	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00253	0.00441	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00239	0.00417	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00236	0.00411	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00235	0.0041	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.0023	0.00402	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.0023	0.00402	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—ADM—bipolar disorder	0.00225	0.00393	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00223	0.0039	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—TACR1—bipolar disorder	0.00219	0.00383	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—TSHB—bipolar disorder	0.00219	0.00383	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00217	0.00378	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00213	0.00373	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00202	0.00352	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DGKH—bipolar disorder	0.00192	0.00336	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00191	0.00333	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR1A—bipolar disorder	0.00182	0.00317	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—TAC1—bipolar disorder	0.00179	0.00312	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD5—bipolar disorder	0.00176	0.00307	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR2C—bipolar disorder	0.00175	0.00306	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD1—bipolar disorder	0.00175	0.00306	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DGKH—bipolar disorder	0.00175	0.00305	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—RGS4—bipolar disorder	0.00173	0.00301	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD3—bipolar disorder	0.0017	0.00297	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.00168	0.00293	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.00166	0.00291	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00165	0.00288	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD4—bipolar disorder	0.00165	0.00288	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD5—bipolar disorder	0.0016	0.00279	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—RGS4—bipolar disorder	0.00157	0.00274	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD2—bipolar disorder	0.00154	0.00268	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00141	0.00247	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00133	0.00233	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADM—bipolar disorder	0.00127	0.00222	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—TSHB—bipolar disorder	0.00124	0.00217	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00124	0.00217	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—TACR1—bipolar disorder	0.00124	0.00217	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—TRPC3—bipolar disorder	0.00121	0.00212	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADM—bipolar disorder	0.00116	0.00202	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00113	0.00197	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—TACR1—bipolar disorder	0.00113	0.00197	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—TSHB—bipolar disorder	0.00113	0.00197	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PDE4B—bipolar disorder	0.00113	0.00197	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AKR1C4—bipolar disorder	0.00112	0.00196	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR2A—bipolar disorder	0.00108	0.00188	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DGKH—bipolar disorder	0.00103	0.0018	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00103	0.00179	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—TAC1—bipolar disorder	0.00101	0.00177	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR2C—bipolar disorder	0.000992	0.00173	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD1—bipolar disorder	0.000992	0.00173	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD3—bipolar disorder	0.00096	0.00168	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD5—bipolar disorder	0.000944	0.00165	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR1A—bipolar disorder	0.000932	0.00163	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD4—bipolar disorder	0.000932	0.00163	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RGS4—bipolar disorder	0.000926	0.00162	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—TAC1—bipolar disorder	0.000918	0.0016	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR2C—bipolar disorder	0.0009	0.00157	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD1—bipolar disorder	0.0009	0.00157	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000878	0.00153	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD3—bipolar disorder	0.000872	0.00152	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD2—bipolar disorder	0.000868	0.00152	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—POMC—bipolar disorder	0.00086	0.0015	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD4—bipolar disorder	0.000847	0.00148	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADCY2—bipolar disorder	0.000797	0.00139	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD2—bipolar disorder	0.000789	0.00138	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TRPC3—bipolar disorder	0.000716	0.00125	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADM—bipolar disorder	0.000683	0.00119	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TACR1—bipolar disorder	0.000665	0.00116	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PDE4B—bipolar disorder	0.000665	0.00116	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TSHB—bipolar disorder	0.000665	0.00116	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000608	0.00106	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	0.000552	0.000964	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR1A—bipolar disorder	0.000551	0.000962	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TAC1—bipolar disorder	0.000542	0.000947	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD1—bipolar disorder	0.000532	0.000929	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR2C—bipolar disorder	0.000532	0.000929	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	0.000517	0.000903	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD3—bipolar disorder	0.000515	0.000899	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	0.000513	0.000896	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD4—bipolar disorder	0.0005	0.000873	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	0.000486	0.000848	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	0.000471	0.000822	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	0.000469	0.000819	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD2—bipolar disorder	0.000466	0.000813	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—POMC—bipolar disorder	0.000441	0.00077	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	0.000422	0.000736	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—S100B—bipolar disorder	0.00041	0.000716	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NRG1—bipolar disorder	0.000362	0.000632	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	0.000326	0.00057	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	0.000263	0.000459	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—POMC—bipolar disorder	0.000261	0.000455	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—INS—bipolar disorder	0.000259	0.000452	CbGpPWpGaD
